Albemarle (ALB) Form 3 ALBEMARLE / Mark Richard Mummert ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Mummert Mark Richard

(Last) (First) (Middle)

4250 CONGRESS ST, SUITE 900

SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/07/2024

3. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP, Capital Projects

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,645(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	02/22/2027	02/22/2034	Common Stock	2,824	118.18	D

Explanation of Responses:

1. The Reporting Person's holdings reported in Table 1, Column 2 include: 4,669 shares of Common Stock; 160 Performance Stock Units ("PSUs") granted on February 26, 2021, which have been earned and will vest on February 26, 2025; 319 Restricted Stock Units ("RSUs") granted on February 26, 2021, which will vest on February 26, 2025; 521 RSUs granted on February 25, 2022, which will vest on February 25, 2025; 812 RSUs granted on February 24, 2023, which will vest on February 24, 2026; and 1,164 RSUs granted on February 22, 2024, which will vest on February 22, 2027. Vesting of all PSUs and RSUs reported above is subject to the terms of the applicable award agreement.

Remarks:

Exhibit List: Exhibit 24 Power of Attorney

	/s/ Stefanie M. Holland, Attorney-in-Fact	05/14/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.